Relationship between in-hospital mortality and creatinine/albumin in patients with ST-elevation myocardial infarction without standard modifiable risk factors

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Dawber TR, Moore FE, Mann GV. Coronary heart disease in the Framingham Study. Am. J. Public Health Nations Health 47, 4–24 (1957).
  Medline CASGoogle Scholar
• 2. Piironen M, Ukkola O, Huikuri H et al. Trends in long-term prognosis after acute coronary syndrome. Eur. J. Prev. Cardiol. 24, 274–280 (2017).
  MedlineGoogle Scholar
• 3. Piepoli MF, Hoes AW, Agewall S et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur. Heart J. 37, 2315–2381 (2016).
  MedlineGoogle Scholar
• 4. Vernon ST, Coffey S, D'Souza M et al. ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors – how common are they, and what are their outcomes? J. Am. Heart Assoc. 8(21), e013296 (2019). •• Large, multicenter study confirming that patients without standard modifiable cardiovascular risk factors have a higher in-hospital mortality rate.
  MedlineGoogle Scholar
• 5. Wang JY, Goodman SG, Saltzman I et al. Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: insights from the Canadian Global Registry of Acute Coronary Events. Can. J. Cardiol. 31(12), 1455–1461 (2015).
  MedlineGoogle Scholar
• 6. Canto JG, Kiefe CI, Rogers WJ et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA 306, 2120–2127 (2011). • Study showing that in-hospital mortality is inversely proportional to the number of risk factors among patients with acute myocardial infarction without pre-existing cardiovascular disease.
  Medline CASGoogle Scholar
• 7. Figtree GA, Vernon ST, Hadziosmanovic N et al. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. Lancet 397, 1085–1094 (2021). •• Study showing higher all-cause mortality in STEMI patients without risk factors, especially women.
  Medline CASGoogle Scholar
• 8. Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105(19), 2259–2264 (2002).
  MedlineGoogle Scholar
• 9. Bertemeu-Gonzalez V, Nunez J, Nunez E et al. A. Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure. Int. J. Cardiol. 112(2), 159–165 (2006). • Study demonstrating the prognosis of renal dysfunction in patients with ST-elevation myocardial infarction.
  MedlineGoogle Scholar
• 10. McCullough PA, Soman SS, Shah SS et al. Risks associated with renal dysfunction in patients in the coronary care unit. J. Am. Coll. Cardiol. 36, 67984 (2000).
  Google Scholar
• 11. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br. J. Anaesth. 85(4), 599–610 (2000).
  Medline CASGoogle Scholar
• 12. Kurtul A, Murat SN, Yarlioglues M et al. Usefulness of serum albumin concentration to predict high coronary SYNTAX score and in-hospital mortality in patients with acute coronary syndrome. Angiology 67(1), 34–40 (2016).
  Medline CASGoogle Scholar
• 13. Kumar D, Banerjee D. Methods of albumin estimation in clinical biochemistry: past, present, and future. Clin. Chim. Acta 469, 150–160 (2017).
  Medline CASGoogle Scholar
• 14. Ibanez B, James S, Agewall S et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39, 119–177 (2018).
  MedlineGoogle Scholar
• 15. Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation 12, 46–52 (2011).
  Google Scholar
• 16. de Marchi SF, Gloekler S, Meier P et al. Determinants of preformed collateral vessels in the human heart without coronary artery disease. Cardiology 118, 198–206 (2011).
  MedlineGoogle Scholar
• 17. Murray CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124–1136 (1986).
  MedlineGoogle Scholar
• 18. Christenson RH, Leino EV, Giugliano RP, Bahr RD. Usefulness of prodromal unstable angina pectoris in predicting better survival and smaller infarct size in acute myocardial infarction (the InTIME-II prodromal symptoms substudy). Am. J. Cardiol. 92, 598–600 (2003).
  MedlineGoogle Scholar
• 19. Hausenloy DJ, Chilian W, Crea F et al. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. Cardiovasc. Res. 115(7), 1143–1155 (2019).
  Medline CASGoogle Scholar
• 20. Aikawa Y, Rohde L, Plehn J et al. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis. Am. Heart J. 141(2), 234–242 (2001).
  Medline CASGoogle Scholar
• 21. Tomoda H, Aoki N. Comparison of protective effects of preinfarction angina pectoris in acute myocardial infarction treated by thrombolysis versus by primary coronary angioplasty with stenting. Am. J. Cardiol. 84, 621–625 (1999).
  Medline CASGoogle Scholar
• 22. Anzai T, Yoshikawa T, Asakura Y et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. J. Am. Coll. Cardiol. 26, 319–327 (1995).
  Medline CASGoogle Scholar
• 23. Thielmann M, Kottenberg E, Kleinbongard P et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single center randomised, double-blind, controlled trial. Lancet 382, 597–604 (2013).
  MedlineGoogle Scholar
• 24. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473–2483 (2006).
  Medline CASGoogle Scholar
• 25. Vis MM, Schaaf RJVD, Sjauw KD et al. Creatinine clearance is independently associated with one-year mortality in a primary PCI cohort with cardiogenic shock. Acute Cardiac. Care 11, 107–112 (2009).
  MedlineGoogle Scholar
• 26. Li S, Zhang Y, Li M, Xie C, Wu H. Serum albumin, a good indicator of persistent organ failure in acute pancreatitis. BMC Gastroenterology 17(1), 59 (2017).
  Medline CASGoogle Scholar
• 27. Arques S. Human serum albumin in cardiovascular diseases. Eur. J. Intern. Med. 52, 8–12 (2018).
  Medline CASGoogle Scholar
• 28. Arques S. Serum albumin and cardiovascular diseases: a comprehensive review of the literature. Annales de Cardiologie et D'angeéiologie 67(2), 82–90 (2018).
  Medline CASGoogle Scholar
• 29. Karahan O, Acet H, Ertas F et al. The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI. Am. J. Emerg. Med. 34(6), 1037–1042 (2016).
  MedlineGoogle Scholar
• 30. Nelson JJ, Liao D, Sharrett AR et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Epidemiol. 151(5), 468–477 (2000). • Important study showing the relationship between serum albumin level and coronary artery disease.
  Medline CASGoogle Scholar
• 31. Oduncu V, Erkol A, Karabay CY et al. The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coron. Artery Dis. 24, 88–94 (2013).
  MedlineGoogle Scholar
• 32. Karahan O, Yavuz C, Kankilic C et al. Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency. Blood Coagul. & Fibrinolysis 27(6), 684–690 (2016).
  Medline CASGoogle Scholar
• 33. Etli M, Karahan O, Serhatlıoglu F, Ontas H. Evaluation of the predictive role of standard laboratory tests for disease severity in patients with deep venous thrombosis. Acta Angiologica 28(1), 16–21 (2022).
  Google Scholar